CL vs KVUE
Colgate-Palmolive and Kenvue, both Consumer Defensive
Colgate-Palmolive is the larger company at $72B against $35B. On trailing earnings KVUE is the cheaper of the two at a P/E of 22.1 against 36.4, a gap that is only a bargain if the two are growing at similar rates. Over the past year CL returned +11% against -6.2% for KVUE. Ryufin's sector-relative Smart Score puts KVUE ahead, 8/10 against 7/10.
| Figure | CL | KVUE |
|---|---|---|
| Last close | $92.06 | $19.22 |
| Market cap | $72B | $35B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 36.4 | 22.1 |
| Dividend yield | 2.3% | 4.3% |
| 1-year return | +11% | -6.2% |
| 5-year return | +30% | n/a |
| Ryufin Smart Scoresector-relative, 1–10 | 7/10 | 8/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Colgate-Palmolive
Revenue of $5.4B in Q2 2026, net income $693M. Its largest reported line is Latin America, 33% of the disclosed total.
Kenvue
Revenue of $4.0B in Q2 2026, net income $456M. Its largest reported line is Self Care, 43% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.